StockData
Elicio Therapeutics, Inc. logo

Elicio Therapeutics, Inc. (ELTX) stock

ELTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$1.43−0.05 (-3.38%)

Close on Nov 17, 2026Market cap $37.58MP/E –Yield –

Elicio Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Elicio Therapeutics's profit margin for the twelve months ending Mar 31, 2023 was -4468.1%. For fiscal 2022 it was -1225.9%, against -192.8% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-1225.9%−1033.1
FY2021Dec 31, 2021-192.8%+2588.7
FY2020Dec 31, 2020-2781.5%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2022Jun 30, 2022-1117.8%+2043.7
Q1 FY2022Mar 31, 2022-428.4%+9460.3
Q4 FY2021Dec 31, 202157.4%+6348.2
Q3 FY2021Sep 30, 2021-1075.6%+1060.9
Q2 FY2021Jun 30, 2021-3161.5%−371.2
Q1 FY2021Mar 31, 2021-9888.7%−8360.1
Q4 FY2020Dec 31, 2020-6290.8%–
Q3 FY2020Sep 30, 2020-2136.5%–
Q2 FY2020Jun 30, 2020-2790.3%–
Q1 FY2020Mar 31, 2020-1528.6%–

More Elicio Therapeutics figures

See a number that looks wrong?